BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30924136)

  • 21. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
    Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T
    Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
    Machnicki MM; Górniak P; Pępek M; Szymczyk A; Iskierka-Jażdżewska E; Steckiewicz P; Bluszcz A; Rydzanicz M; Hus M; Płoski R; Makuch-Łasica H; Nowak G; Juszczyński P; Jamroziak K; Stokłosa T; Puła B
    Eur J Haematol; 2021 Mar; 106(3):320-326. PubMed ID: 33190294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
    Tausch E; Beck P; Schlenk RF; Jebaraj BJ; Dolnik A; Yosifov DY; Hillmen P; Offner F; Janssens A; Babu GK; Grosicki S; Mayer J; Panagiotidis P; McKeown A; Gupta IV; Skorupa A; Pallaud C; Bullinger L; Mertens D; Döhner H; Stilgenbauer S
    Haematologica; 2020 Oct; 105(10):2440-2447. PubMed ID: 33054084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
    Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
    Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
    Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
    Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
    Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
    Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.
    Kim JA; Hwang B; Park SN; Huh S; Im K; Choi S; Chung HY; Huh J; Seo EJ; Lee JH; Bang D; Lee DS
    PLoS One; 2016; 11(12):e0167641. PubMed ID: 27959900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.
    Tripathi R; Lee-Verges E; Higashi M; Gimenez N; Rosich L; Lopez-Guerra M; Colomer D
    Expert Opin Drug Discov; 2017 Oct; 12(10):1041-1052. PubMed ID: 28776453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.
    Jeromin S; Weissmann S; Haferlach C; Dicker F; Bayer K; Grossmann V; Alpermann T; Roller A; Kohlmann A; Haferlach T; Kern W; Schnittger S
    Leukemia; 2014 Jan; 28(1):108-17. PubMed ID: 24113472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
    Shuai W; Lin P; Strati P; Patel KP; Routbort MJ; Hu S; Wei P; Khoury JD; You MJ; Loghavi S; Tang Z; Fang H; Thakral B; Medeiros LJ; Wang W
    Blood Cancer J; 2020 Aug; 10(8):86. PubMed ID: 32848129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.
    Willander K; Dutta RK; Ungerbäck J; Gunnarsson R; Juliusson G; Fredrikson M; Linderholm M; Söderkvist P
    BMC Cancer; 2013 Jun; 13():274. PubMed ID: 23734977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.
    Raponi S; Del Giudice I; Marinelli M; Wang J; Cafforio L; Ilari C; Piciocchi A; Messina M; Bonina S; Tavolaro S; Bordyuh M; Mariglia P; Peragine N; Mauro FR; Chiaretti S; Molica S; Gentile M; Visentin A; Trentin L; Rigolin GM; Cuneo A; Diop F; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
    Ann Oncol; 2018 Apr; 29(4):966-972. PubMed ID: 29365086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
    Vetro C; Haferlach T; Jeromin S; Stengel A; Zenger M; Nadarajah N; Baer C; Weissmann S; Kern W; Meggendorfer M; Haferlach C
    Br J Haematol; 2018 Oct; 183(1):47-59. PubMed ID: 30022491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
    Nabhan C; Raca G; Wang YL
    JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
    Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
    Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.
    Sadria R; Motamed N; Saberi Anvar M; Mehrabani Yeganeh H; Poopak B
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1757. PubMed ID: 36411516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.
    Zakrzewska E; Pirog M; Purkot J; Giannopoulos K
    Folia Histochem Cytobiol; 2017; 55(3):95-106. PubMed ID: 28994094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.